Combozil


Active Ingredient

Lamivudine + Zidovudine

Strength

150/300 mg

Pack Size

60 tablets

Scheduling Status

S4

Reg No.

43/20.2.8/0362

Indications

To be used as part of antiretroviral combination therapy for the treatment of HIV infected adults & children over 12 years of age, with progressive immunodeficiency (CD4 + count 500 cells//mm).

For full prescribing information, please refer to the package insert approved by the Medicines Regulation Authority.